Sebastian Kollenda

Mr. Sebastian Kollenda

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2020 in Acta Biomaterialia
Verified
Journal Article
Closed access
SKSebastian Kollenda
Sebastian Kollenda
JKJasmin Klose
Jasmin Klose
TKTorben Knuschke
Torben Knuschke
VSViktoriya Sokolova
Viktoriya Sokolova
JSJochen Schmitz
Jochen Schmitz
MEMatthias Epple
Matthias Epple

22 September 2017 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
EPEva Pastille
Eva Pastille
AFAnnika Frede
Annika Frede
HMHenry J. McSorley
Henry J. McSorley
JGJessica Gräb
Jessica Gräb
AAAlexandra Adamczyk
Alexandra Adamczyk
AWAstrid M. Westendorf
Astrid M. Westendorf
Inflammatory bowel diseases (IBD) are chronic inflammatory disorders of the gastrointestinal tract, strongly associated with an increased risk of colorectal cancer development. Parasitic infections caused by helminths have been shown to modulate the host’s immune response by releasing immunomodulatory molecules and inducing regulatory T cells (Tregs). This immunosuppressive state provoked in the host has been considered as a novel and promising approach to treat IBD patients and alleviate acute intestinal inflammation. On the contrary, specific parasite infections are well known to be directly linked to carcinogenesis. Whether a helminth infection interferes with the development of colitis-associated colon cancer (CAC) is not yet known. In the present study, we demonstrate that the treatment of mice with the intestinal helminth Heligmosomoides polygyrus at the onset of tumor progression in a mouse model of CAC does not alter tumor growth and distribution. In contrast, H. polygyrus infection in the early inflammatory phase of CAC strengthens the inflammatory response and significantly boosts tumor development. Here, H. polygyrus infection was accompanied by long-lasting alterations in the colonic immune cell compartment, with reduced frequencies of colonic CD8+ effector T cells. Moreover, H. polygyrus infection in the course of dextran sulfate sodium (DSS) mediated colitis significantly exacerbates intestinal inflammation by amplifying the release of colonic IL-6 and CXCL1. Thus, our findings indicate that the therapeutic application of helminths during CAC might have tumor-promoting effects and therefore should be well-considered. Evidence from epidemiological studies indicates an inverse correlation between the incidence of certain immune-mediated diseases, including inflammatory bowel diseases, and exposure to helminths. As a consequence, helminth parasites were tested for treating IBD patients, resulting in clinical amelioration of the disease due to the induction of an immunosuppressive microenvironment. However, some infection–related cancers can be attributed to helminth infection, probably due to the generation of a microenvironment that might be conductive to the initiation and development of cancer. In the present study, we aimed to unravel the apparently controversial function of helminths in a mouse model of colitis-associated colon cancer. We show that helminth infection in the onset of colitis and colitis-associated colon cancer does not ameliorate colonic inflammation but activates intestinal immune cells that further facilitate tumor development. Therefore, a better understanding of mechanisms by which helminths modulate host immune responses in the gut should be defined precisely before application of helminths in autoimmune diseases like IBD.

1 June 2019 in Molecular Cancer Therapeutics
Verified
Journal Article
Closed access
PDF file
CHCarolin Heße
Carolin Heße
SKSebastian Kollenda
Sebastian Kollenda
OROlga Rotan
Olga Rotan
EPEva Pastille
Eva Pastille
AAAlexandra Adamczyk
Alexandra Adamczyk
TKTorben Knuschke
Torben Knuschke
Recognition of immunoactive oligonucleotides by the immune system, such as Toll-like receptor ligand CpG, leads to increased antibody and T-cell responses. Systemic application often results in unwanted generalized nonantigen-specific activation of the immune system. Nanoparticles are ideal carriers for small and large molecules. Recently, we have demonstrated that calcium phosphate (CaP) nanoparticles functionalized with CpG, and viral antigens are able to induce specific T-cell immunity that protects mice against viral infection and efficiently reactivates the exhausted CD8+ T-cell compartment during chronic retroviral infection. Therefore, CaP nanoparticles are promising vaccine vehicles for therapeutic applications. In this study, we investigated the therapeutic potential use of these nanoparticles in a murine xenograft colorectal cancer model. Therapeutic vaccination with CaP nanoparticles functionalized with CpG and tumor model antigens increased the frequencies of cytotoxic CD8+ T cells in the tumor in a type I interferon-dependent manner. This was accompanied with significantly repressed tumor growth in contrast to the systemic administration of soluble CpG and antigens. Combination therapy of CaP nanoparticles and immune checkpoint blocker against PD-L1 further enhanced the cytotoxic CD8+ T-cell response and eradicated the tumors. Strikingly, vaccination with CaP nanoparticles functionalized with CpG and a primary tumor cell lysate was also sufficient to control the tumor growth. In conclusion, our results represent a translational approach for the use of CaP nanoparticles as a potent cancer vaccine vehicle.

1 July 2020 in Acta Biomaterialia
Verified
Journal Article
Closed access
SKSebastian Kollenda
Sebastian Kollenda
MKMathis Kopp
Mathis Kopp
JWJasmin Wens
Jasmin Wens
JKJohannes Koch
Johannes Koch
NSNina Schulze
Nina Schulze
MEMatthias Epple
Matthias Epple

1 March 2020 in Vaccines
Verified
Journal Article
Open access
PDF file
FSFlorian Scheffel
Florian Scheffel
TKTorben Knuschke
Torben Knuschke
LOLucas Otto
Lucas Otto
SKSebastian Kollenda
Sebastian Kollenda
VSViktoriya Sokolova
Viktoriya Sokolova
AWAstrid M. Westendorf
Astrid M. Westendorf
The ability of vaccines to induce T cell responses is crucial for preventing diseases caused by viruses. Nanoparticles (NPs) are considered to be efficient tools for the initiation of potent immune responses. Calcium phosphate (CaP) NPs are a class of biodegradable nanocarriers that are able to deliver immune activating molecules across physiological barriers. Therefore, the aim of this study was to assess whether Toll-like receptor (TLR) ligand and viral antigen functionalized CaP NPs are capable of inducing efficient maturation of human antigen presenting cells (APC). To achieve this, we generated primary human dendritic cells (DCs) and stimulated them with CpG or poly(I:C) functionalized CaP NPs. DCs were profoundly stronger when activated upon NP stimulation compared to treatment with soluble TLR ligands. This is indicated by increased levels of costimulatory molecules and the secretion of proinflammatory cytokines. Consequently, coculture of NP-stimulated APCs with CD8+ T cells resulted in a significant expansion of virus-specific T cells. In summary, our data suggest that functionalized CaP NPs are a suitable tool for activating human virus-specific CD8+ T cells and may represent an excellent vaccine delivery system.

8 November 2017 in ACS Chemical Biology
Verified
Journal Article
Closed access
LRLaura Roszyk
Laura Roszyk
SKSebastian Kollenda
Sebastian Kollenda
SHSven Hennig
Sven Hennig